|2.||Breast Diseases (Breast Disease)
|3.||Endometrial Neoplasms (Endometrial Cancer)
|4.||Dysmenorrhea (Menstrual Pain)
|5.||Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases)
|1.||Kolwijck, Eva: 6 articles (07/2010 - 08/2009)|
|2.||Archbald, L F: 6 articles (09/2006 - 05/2003)|
|3.||Sundfeldt, Karin: 5 articles (01/2015 - 12/2011)|
|4.||Massuger, Leon F A G: 5 articles (07/2010 - 08/2009)|
|5.||Boss, E A: 5 articles (01/2008 - 08/2000)|
|6.||Boonstra, H: 5 articles (01/2008 - 08/2000)|
|7.||Partheen, Karolina: 4 articles (10/2014 - 12/2011)|
|8.||Fung, Eric T: 4 articles (10/2014 - 01/2012)|
|9.||Vercellini, Paolo: 4 articles (09/2014 - 03/2007)|
|10.||Somigliana, Edgardo: 4 articles (09/2014 - 09/2005)|
11/01/2014 - "Oral contraceptives are not an effective treatment for ovarian cysts."
12/01/2000 - "In conclusion, expectant management is as effective as oral contraceptives for the resolution of functional ovarian cysts induced by ovarian stimulation. "
01/01/2014 - "We included randomized controlled trials in any language that included oral contraceptives used for treatment and not prevention of functional ovarian cysts. "
01/01/2014 - "This review examined all randomized controlled trials that studied oral contraceptives as therapy for functional ovarian cysts. "
01/01/2011 - "We included randomized controlled trials in any language that included oral contraceptives used for treatment and not prevention of functional ovarian cysts. "
|2.||Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/01/1998 - "Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues."
11/01/1982 - "To be effective in reducing the incidence of ovarian cysts, GnRH should be administered about 2 wk postpartum. "
03/01/2006 - "The objective of this study was to determine the incidence of ovarian cyst formation following GnRH agonist administration and to examine their effect on IVF outcome. "
05/01/2003 - "From the results of this study, it was concluded that bST pretreatment decreased CR, and pretreatment with GnRH, and GnRH with bST tended to decrease CR in lactating dairy cows with ovarian cysts concurrently treated with bST and subjected to the Ovsynch protocol."
10/15/2002 - "For the second study, 128 cows with ovarian cysts were randomly assigned to one of two treatment groups: cows in Group Ovsynch (n = 64) were treated with 100 microg GnRH i.m. "
|3.||Estradiol (Estrace)FDA LinkGeneric
02/01/2015 - "An average in vivo release of 277 µg/day/animal of ATZ for one menstrual cycle was effective in causing a decrease of systemic estradiol (E₂) levels by ∼30% without inducing counter regulation such as the elevation of FSH or the formation of ovarian cysts. "
12/15/1969 - "[Studies on the beta-estradiol content in the serum and cyst fluid of cows in different phases of the sexual cycles, with ovarian cysts and hypoplasia of the ovary]."
12/01/2010 - "The patient is currently undergoing estradiol therapy to suppress ovarian cyst formation."
10/01/2003 - "SONX restored cyclicity in these animals, normalized LH, estradiol, ovarian 3beta-HSD activities, and ovarian dynamics as evidenced by the disappearance of ovarian cysts and appearance of corpus luteum and restored corpus luteum function. "
08/01/1999 - "None of the 4 heifers responded to estradiol after ovarian cyst formation. "
08/01/2003 - "In the present study, we examined the outcome of assisted reproductive technology cycles in patients with or without baseline ovarian cysts following gonadotrophin-releasing hormone analogs administration. "
02/01/2015 - "To investigate changes in serum anti-Müllerian hormone (AMH) concentrations following ovarian cyst surgery, and predictors of these changes. "
03/01/2014 - "Surgical impact on serum anti-Müllerian hormone in women with benign ovarian cyst: A prospective study."
09/01/2007 - "Thyroid hormone replacement seems to be the best therapeutic approach in some patients, but, in some, complete resolution of the ovarian cysts does not occur after 3 months."
04/01/2007 - "These observations are in distinct contrast to our previous observations that tonic stimulation by FSH + hCG results in the induction of large ovarian cysts in HYPOXD rats and provide tantalizing new insights regarding the potential importance of specific hormones at the level of the ovary in the induction of specific types of cystic follicles."
|5.||norethindrone acetate (Norlutate)FDA LinkGeneric
05/01/1996 - "A protocol utilizing both leuprolide acetate (LA) and norethindrone acetate (NETA) in subjects undergoing ovarian suppression prior to follicle aspiration proved more effective than LA alone in reducing the incidence of ovarian cyst formation without affecting clinical outcome. "
03/01/2014 - "To compare the efficacy of norethisterone acetate (NETA; group N) or letrozole combined with NETA (group L) in treating endometriotic ovarian cysts. "
01/01/2002 - "During the study period five of 38 tamoxifen-treated postmenopausal patients (13.2%) had ovarian cysts. "
07/06/2010 - "Tamoxifen is a high risk factor for an increased risk of endometrial lesions for menopausal women and ovarian cysts for premenopausal women. "
12/01/2008 - "Ovarian cyst was found in 32 women and the most were developed in premenopausal women receiving tamoxifen (30/32). "
01/01/2008 - "Moreover, the incidence of functional ovarian cysts is significantly high in premenopausal tamoxifen users. "
10/01/2005 - "We have described an association between pre-menopausal patients using tamoxifen with high E(2) level and ovarian cyst enlargement."
01/01/1982 - "[Experimental studies of progesterone therapy in ovarian cysts of cattle]."
10/15/2015 - "These findings indicate that ovarian cysts in COD are similar in many ways to the persistent follicles induced by progesterone, with an analogous hormonal and morphologic context, thus confirming a local role of subluteal levels of progesterone in COD pathogenesis and in the regulatory mechanisms of the ovarian function."
07/15/2015 - "Ovarian cysts were diagnosed by ultrasonography, and resumption of postpartum cyclicity was evaluated by progesterone concentrations (≥1 ng/mL) at 4, 6, and 8 weeks postpartum. "
07/01/2008 - "Elevated serum progesterone with or without elevated serum 17alpha-hydroxyprogesterone and recurrent ovarian cysts are typical manifestations of partial 17OHD. "
10/01/2007 - "Ovarian disorders were common in RBCs, and included ovarian cysts, mistimed AI, subluteal progesterone levels, luteal dysfunction or ovulation defects. "
|8.||Estrogens (Estrogen)FDA Link
11/01/1990 - "Estrogen (E)/progestin therapy for functional ovarian cysts is widely used in clinical practice, but the efficacy of this treatment has not been determined in controlled trials. "
06/01/1993 - "Available studies on breast effects and cycle control, the incidence of ovarian cysts, metabolic effects, and the persistence of other beneficial effects of higher-dosed OCs suggest that the disadvantages of reducing estrogen doses are minor. "
02/14/2011 - "Application of porous membrane protected micro-solid-phase-extraction combined with gas chromatography-mass spectrometry for the determination of estrogens in ovarian cyst fluid samples."
04/01/2007 - "Further, the data also indicate that, at least in HYPOXD rats, combined, tonic stimulation by FSH plus estrogen and androgen is sufficient for the development of small, polyfollicular ovarian cysts in a "string of pearls" pattern. "
07/01/2003 - "As evaluated by ultrasound after an 8-month recovery period, uterine size was not affected by exogenous estrogen, but there was some indication of increased incidence of ovarian cysts/masses in MXC- and DES-treated groups. "
01/01/2013 - "A total of 30 bitches with ovarian cysts were treated with a maximum of three attempts per individual, utilising different protocols of the hCG and/or buserelin treatment. "
12/01/1998 - "To assess the effect of pretreatment with an oral contraceptive (OC) on ovarian cyst formation during pituitary suppression with buserelin acetate. "
11/01/1991 - "polycystic ovaries, ovarian cysts) rather than the dose and mode of administration of buserelin, are the major determinant of the length of time needed for pituitary down-regulation. "
07/01/1990 - "The length of time taken to achieve pituitary desensitisation is increased in patients who have PCOD or who form ovarian cysts in response to the administration of buserelin.(ABSTRACT TRUNCATED AT 250 WORDS)"
01/01/1987 - " After 2 weeks of Buserelin in a 1st treatment cycle, ovarian scans revealed follicular development in 68% of cases--4-10 mm follicles in 24%, 10-27 mm developing follicles in another 24%, and ovarian cysts greater than 27 mm in 20%. "
04/01/2004 - "Laparoscopic management of large ovarian cysts: more than cosmetic considerations."
10/01/2002 - "Laparoscopy offers a safe, effective, and cosmetic means of managing perinatal torsion of ovarian cysts."
07/01/2011 - "Our small study demonstrates that laparoscopy is as safe and effective as classical laparotomy in managing neonatal ovarian cysts, but with better cosmetic results."
12/01/2012 - "The authors demonstrated that laparoscopic cystectomy was a technically feasible and safe method in the treatment of benign ovarian cysts, associated with short hospitalization, minimal analgesic requirement, and a good cosmetic appearance."
08/01/2014 - "When treating a giant ovarian cyst, management of inferior vena cava (IVC) syndrome, bleeding, abdominal competence, and cosmetic appearance are difficult. "
12/01/2006 - "The current available evidence suggests that the laparoscopic approach is superior to laparotomy for the surgical management of benign ovarian cysts. "
05/01/2013 - "Operative laparoscopy compared with laparotomy has been established as the gold standard surgical approach in treating ovarian cysts. "
03/01/2014 - "The aim of the present study was to evaluate the surgical and obstetric results of laparoscopy versus laparotomy in the management of ovarian cyst during pregnancy. "
03/01/2012 - "Morphological study of the residual ovarian tissue removed by laparoscopy or laparotomy in adolescents with benign ovarian cysts."
09/01/2000 - "The purpose of our study was to compare operative procedures, histologic types of tumours, and intra- and postoperative complications of patients operated for benign ovarian cysts by laparotomy or laparoscopy. "
|2.||Contraception (Birth Control)
10/01/2009 - "The case shows that low-dose hormonal contraception could protect to development of functional ovarian cysts. "
10/01/2009 - "[Combined hormonal contraception in woman with persistent functional ovarian cysts--case report]."
06/01/2009 - "No women using combined oral contraception developed ovarian cysts. "
10/01/2006 - "In 58% of women effective contraception was the mean indication for the therapy, in the remaining group pills were indicated additionally for the development of ovarian cysts and excessive menstrual bleedings. "
03/16/2005 - "to check the position of IUDs, confirm the suppression of ovarian follicle activity in women taking ovulation inhibitors, detect ovarian cysts as a focus of undesirable hormonal activity, etc. In some cases, the failure of contraception, namely pregnancy, can be diagnosed by ultrasound. "
08/01/2003 - "Ultrasound-guided alcoholic sclerotherapy of the endometriotic ovarian cysts is effective and safe. "
02/01/2011 - "Recurrence of ovarian cyst after sclerotherapy."
07/01/2009 - "Percutaneous drainage without sclerotherapy for benign ovarian cysts."
04/01/2003 - "Management of non-neoplastic ovarian cysts with sclerotherapy."
07/01/2009 - "In patients considered poor candidates for open surgery or laparoscopy, percutaneous treatment of ovarian cysts with short-term catheter drainage without sclerotherapy appears to be a safe and effective alternative, with low recurrence rates."
10/01/2015 - "She had a right, simple-appearing ovarian cyst, which had increased in size from previous ultrasounds to 12.8 × 13.4 × 15.7 cm. Ultrasound-guided percutaneous drainage with pigtail catheter placement removed 1.2 L serous green fluid. "
07/01/2009 - "Thirty-eight patients with simple ovarian cysts were treated with drainage of fluid content by catheters until output stopped. "
07/01/2009 - "To evaluate percutaneous short-term catheter drainage in the management of benign ovarian cysts in patients at increased surgical risk. "
03/01/2008 - "Culdotomy using transvaginal sonography and a Nephromax balloon dilator catheter was performed in 16 patients for the vaginal removal of benign ovarian cysts located in the cul-de-sac. "
11/01/2005 - "A 44-year-old woman receiving home hyperalimetation with an implanted port catheter, was scheduled to undergo resection of ovarian cyst and adhesiotomy. "
10/01/2009 - "Electrocoagulation after laparoscopic excision of ovarian cysts is associated with a statistically significant reduction in ovarian reserve, which is partly a consequence of the damage to the ovarian vascular system."
10/01/2009 - "The impact of electrocoagulation on ovarian reserve after laparoscopic excision of ovarian cysts: a prospective clinical study of 191 patients."
10/01/2009 - "To investigate the impact of electrocoagulation on ovarian reserve after laparoscopic excision of ovarian cysts and the possible mechanisms. "
08/01/2004 - "Our results suggest that bipolar electrocoagulation of the ovarian parenchyma after laparoscopic stripping of an endometriotic ovarian cyst adversely affects ovarian function."
04/01/2013 - "Comparison of the effects of laparoscopic bipolar electrocoagulation and intracorporeal suture application to ovarian reserve in benign ovarian cysts."